Amphora Research has launched a new payment programme for its the PatentSafe software, which will make the ELN software more accessible for smaller biotech companies.
The 'starter pack subscription' will apply to companies with fewer than 10 scientists, which typically have the same requirements as larger companies, without the funds to but to deploy an ELN package.
Simon Coles, CTO and co-founder of Amphora, explained: 'The introduction of the PatentSafe Starter Pack allows these smaller biotech companies to use a class of product that was previously unavailable to them. Therefore, their scientists will be more productive and it will be easier for the company to sell or license their IP.'